Identification of Antifungal H + -ATPase Inhibitors with Effect on Plasma Membrane Potential
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The plasma membrane H + -ATPase (Pma1) is an essential fungal protein and a proposed target for new antifungal medications. The compounds in a small-molecule library containing ∼191,000 commercially available compounds were screened for their ability to inhibit Saccharomyces cerevisiae plasma membranes containing Pma1. The overall hit rate was 0.2%, corresponding to 407 compounds. These hit compounds were further evaluated for ATPase selectivity and broad-spectrum antifungal activity. Following this work, one Pma1 inhibitor series based on compound 14 and analogs was selected for further evaluation. This compound series was able to depolarize the membrane and inhibit extracellular acidification in intact fungal cells concomitantly with a significant increase in intracellular ATP levels. Collectively, we suggest that these effects may be a common feature of Pma1 inhibitors. Additionally, the work uncovered a dual mechanism for the previously identified cationic peptide BM2, revealing fungal membrane disruption, in addition to Pma1 inhibition. The methods presented here provide a solid platform for the evaluation of Pma1-specific inhibitors in a drug development setting. The present inhibitors could serve as a starting point for the development of new antifungal agents with a novel mode of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comparable ATP accumulation and mitochondrial participation have been reported in C. albicans exposed to hLf, defensins, the BM2 peptide, and pharmacological inhibitors of Pma1 [27,28,30,31,37].”
From Ovotransferrin and Its γ-Core-Containing Peptides Impair Pma1-Dependent Proton Homeostasis in Candida albicans (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A simple cell-based phenotype characterized by plasma membrane depolarization, intracellular ATP accumulation, and defective glucose-induced extracellular acidification has been proposed as a functional signature of impaired Pma1-dependent proton extrusion and used as a screening approach to identify antifungal agents that inhibit Pma1 activity [37].”
From Ovotransferrin and Its γ-Core-Containing Peptides Impair Pma1-Dependent Proton Homeostasis in Candida albicans (2026) · cites this paper as [37]
The cited source says what the claim attributes to it.
In the citing paper
“This supports the idea that this phenotype is not simply a nonspecific consequence of cell death, but rather a reproducible signature of impaired proton homeostasis [37].”
From Ovotransferrin and Its γ-Core-Containing Peptides Impair Pma1-Dependent Proton Homeostasis in Candida albicans (2026) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · cited 1×
“Invasive fungal infections are less common but of much greater concern because they are associated with extremely high mortality rates (20 to 90%) (2).”
BackgroundA Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042 · cited 2×
“False-positive hits may also result from unspecific protein inhibition activity in a homogeneous assay setup (20, 21).”
BackgroundSerrano, R., Kielland-Brandt, M. C., & Fink, G. R. (1986) · Nature · doi:10.1038/319689a0 · Cited by 813 · cited 1×
“The proton pump is essential for fungal growth, as shown by knockout studies (7).”
BackgroundLingrel, J. B., & Kuntzweiler, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32067-7 · Cited by 744
The proton-translocating ATPase of the fungal plasma membrane
Goffeau, A., & Slayman, C. W. (1981) · Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics · doi:10.1016/0304-4173(81)90010-0 · Cited by 493
An insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432 · cited 8×
“cerevisiae cells exposed to compound 14 yielded an elevated DiBAC4(3) signal after 5 min of exposure, while only a minimal increase of the PI signal was observed (Fig.”
BackgroundMethodInfluentialFoxman, B., Muraglia, R., Dietz, J.-P., Sobel, J. D., & Wagner, J. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318273e8cf · Cited by 261 · cited 1×
“In a survey of women (age 16 years and older, n 6,000), up to 49% had been diagnosed with vulvovaginal candidiasis (VVC), depending upon their ethnic origin, and approximately 20% of those women experienced recurrent VVC in a 12-month follow-up period (1), with a pronounced impact on quality of life.”
BackgroundThe early research and development of ebselen
Parnham, M. J., & Sies, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.028 · Cited by 229 · cited 1×
“several enzymes and modify a range of biological activities (15).”
BackgroundBiological assay challenges from compound solubility: strategies for bioassay optimization
Di, L., & Kerns, E. H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.004 · Cited by 181 · cited 2×
“False-positive hits may also result from unspecific protein inhibition activity in a homogeneous assay setup (20, 21).”
BackgroundGradmann, D., Hansen, U., Long, W. S., Slayman, C. L., & Warncke, J. (1978) · The Journal of Membrane Biology · doi:10.1007/bf01869898 · Cited by 166 · cited 1×
“It has been measured to be 175 mV within the fungal species Neurospora crassa (19).”
Background
Research works printed but not linked: 1
- Shah T, Singh N, Goyal R, Dev A, Chhabria M, Shishoo C 1995 Pharmacological evaluation of LM-2616: a beta1-adrenoceptor antagonist with beta2-adrenoceptor agonistic activity. Pharmacol Commun 5: 253– 266.
Cited by
Structure and activation mechanism of the hexameric plasma membrane H+-ATPase
Zhao, P., Zhao, C., Chen, D., Yun, C., Li, H., & Bai, L. (2021) · Nature Communications · doi:10.1038/s41467-021-26782-y · Cited by 86
Taveira, G. B., Mello, É. D. O., de Souza, S. B., Monteiro, R. M., Ramos, A. C., Carvalho, A. D. O., Rodrigues, R., Okorokov, L. A., & Gomes, V. M. (2018) · Bioscience Reports · doi:10.1042/bsr20180119 · Cited by 47
Marchesini, M., Gherli, A., Montanaro, A., Patrizi, L., Sorrentino, C., Pagliaro, L., Rompietti, C., Kitara, S., Heit, S., Olesen, C., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.04.002 · Cited by 46
“To identify potent P-type ATPase inhibitors in this context, Kjellerup and colleagues screened a library containing nearly 191 000 compounds for inhibition of the fungal H+ATPase (Kjellerup et al., 2017).”
BackgroundInfluentialSelf-citationCohrt, K. A. O., Marín, L., Kjellerup, L., Clausen, J. D., Dalby-Brown, W., Calera, J. A., & Winther, A.-M. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02024-17 · Cited by 32
Self-citationElucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives
Clausen, J. D., Kjellerup, L., Cohrt, K. O., Hansen, J. B., Dalby‐Brown, W., & Winther, A.-M. L. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.067 · Cited by 33
Self-citationDias, L. P., Santos, A. L. E., Araújo, N. M. S., Silva, R. R. D. S., Santos, M. H. C., Roma, R. R., Rocha, B. A. M., Oliveira, J. T. A., & Teixeira, C. S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.236 · Cited by 33
Tetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activity
Bublitz, M., Kjellerup, L., Cohrt, K. O., Gordon, S. L., Mortensen, A. L., Clausen, J. D., Pallin, T. D., Hansen, J. B., Fuglsang, A. T., Dalby‐Brown, W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0188620 · Cited by 32
“They were also more potent than other, structurally different compound series identified in this and previous library screens, the carbazoles [11] and the pyrido-thienopyrimidines [12].”
BackgroundSelf-citationA Comparative Review of Eugenol and Citral Anticandidal Mechanisms: Partners in Crimes Against Fungi
Shahina, Z., & Dahms, T. E. S. (2024) · Molecules · doi:10.3390/molecules29235536 · Cited by 34
“…organelles found in all eukaryotes, contribute to energy production through the electron transport chain and therefore produce reactive oxygen species (ROS) [60], but also maintain cell physiology by controlling the cell cycle, cell growth, signaling, ion homeostasis and metabolite production [61].”
Sirakanyan, S. N., Spinelli, D., Geronikaki, A. A., Hakobyan, E. K., Sahakyan, H., Arabyan, E., Zakaryan, H. S., Nersesyan, L. E., Aharonyan, A. S., Danielyan, I. S., et al. (2019) · Molecules · doi:10.3390/molecules24213952 · Cited by 27
“In particular, these compounds are PI3 kinase p110a [8] and phosphodiesterase type 4 [9] inhibitors, and they possess antimicrobial [10] and antifungal [11] activities.”
BackgroundA New Front in Microbial Warfare—Delivery of Antifungal Effectors by the Type VI Secretion System
Trunk, K., Coulthurst, S. J., & Quinn, J. (2019) · Journal of Fungi · doi:10.3390/jof5020050 · Cited by 29
“In S. cerevisiae, membrane potential is controlled mainly by the regulation of proton and potassium cation fluxes, with the main regulator being the extensively studied and well-characterised Pma1 H+-ATPase [53].”
BackgroundSanad, S. M. H., & Mekky, A. E. M. (2021) · Canadian Journal of Chemistry · doi:10.1139/cjc-2021-0121 · Cited by 26
Sanad, S. M. H., & Mekky, A. E. M. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.135236 · Cited by 25
Zhgun, A. A., Dumina, M. V., Valiakhmetov, A., & Eldarov, M. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238452 · Cited by 26
“At the same time, when PMA1 is inhibited by various drugs, unused ATP can accumulate in the cell [79].”
BackgroundThe Effect of Honokiol on Ergosterol Biosynthesis and Vacuole Function inCandida albicans
Sun, L., & Liao, K. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2008.08019 · Cited by 27
“Upon glucose activation, it extrudes protons out of cells to maintain normal intracellular pH and acidifies the extracellular medium [30, 31].”
BackgroundRecent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins
Saini, V., Safwan, S. M., Mehta, D., Das, E. E., & Bajaj, A. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00828 · Cited by 25
Lee, H.-J., Hwang, J. S., & Lee, D. G. (2019) · Biochemical Journal · doi:10.1042/bcj20180933 · Cited by 24
Havshøi, N. W., & Fuglsang, A. T. (2022) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13221 · Cited by 24
Self-citationStructure, function and biogenesis of the fungal proton pump Pma1
Young, M. R., Heit, S., & Bublitz, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119600 · Cited by 21
Ottilie, S., Goldgof, G. M., Cheung, A. L., Walker, J. L., Vigil, E., Allen, K. E., Antonova‐Koch, Y., Slayman, C. W., Suzuki, Y., & Durrant, J. D. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0261-3 · Cited by 20
Sirakanyan, S. N., Spinelli, D., Geronikaki, A. A., Карцев, В. Г., Hakobyan, E. K., & Hovakimyan, A. A. (2019) · Synthetic Communications · doi:10.1080/00397911.2019.1595659 · Cited by 18
Dunphy, A. M., Patel, K., Belperain, S., Pennington, A., Chiu, N. H. L., Yin, Z., Zhu, X., Priebe, B., Tian, S., Wei, J., et al. (2021) · Nanomaterials · doi:10.3390/nano11051116 · Cited by 16
“4-Aminopyridine ~98% C5H6N2 Ion channel blocker (K+) [18] Amiodarone Hydrochloride Amiodarone HCL Non-selective ion channel blocker [19] Barium Chloride Anhydrous BaCL2 Ion channel blocker (K+) [18] Chlorpromazine HCL Chlorpromazine HCL Suppresses clathrin disassembly [20,21] Cobalt (II) Chloride CoCL2 Ion channel blo…”
BackgroundTesting the polar auxin transport model with a selective plasma membrane H+‐ATPase inhibitor
Yang, Y., Liu, X., Guo, W., Liu, W., Shao, W., Zhao, J. Y., Li, J., Dong, Q., Ma, L., He, Q., et al. (2022) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13256 · Cited by 16
Belperain, S., Kang, Z. Y., Dunphy, A. M., Priebe, B., Chiu, N. H. L., & Jia, Z. (2021) · Nanomaterials · doi:10.3390/nano11051247 · Cited by 18
“Inhibitor Name Abbrev Concentrate Function 4-Aminopyridine ~98% 4-AP 5 mM Ion channel blocker (K+) [35] Amiloride Hydrochloride Dihydrous Amil 50 µM Inhibits micropinocytosis: blocks Na+/H+ exchanger pump [36–38] Amiodarone Hydrochloride Amio 10 µM Non-selective ion channel blocker [39] Amlodipine Aml 10 µM Ion channe…”
BackgroundInfluentialTeleb, M. A. M., Mekky, A. E. M., & Sanad, S. M. H. (2021) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4313 · Cited by 15
A review on lactoferrin as a proton pump inhibitor
Santos-Pereira, C., Andrés, M. T., Fierro, J. F., Rodrigues, L. R., & Côrte-Real, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.075 · Cited by 13
Vela-Corcia, D., Hierrezuelo, J., Pérez-Lorente, A. I., Stincone, P., Pakkir Shah, A. K., Grélard, A., Zi-Long, Y., de Vicente, A., Pérez García, A., Bai, L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06947-3 · Cited by 13
“Thus, our fi ndings support the rationale of using Pma1 as a target for designing novel antifungal molecules 42 – 44 .”
BackgroundAnti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking and in vitro Studies
Thakuria, D., Khangembam, V. C., Pant, V., Bhat, R. A. H., Tandel, R. S., Siva, C., Pande, A., & Pandey, P. K. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.909570 · Cited by 11
“Similarly, TKL protein kinase and plasma membrane ATPase are important proteins that can be targeted for the discovery of antifungal agents (49, 50).”
BackgroundSanad, S. M. H., & Mekky, A. E. M. (2023) · Synthetic Communications · doi:10.1080/00397911.2023.2204192 · Cited by 11
“These hybrids have also shown potential as antimicrobial([27,28]) antifungal,([29]) anticancer,([30]) and antitumor agents.”
BackgroundTùng, T. T., Đào, T. T., Grifell-Junyent, M., Palmgren, M. B., Pomorski, T. G., Fuglsang, A. T., Christensen, S. B., & Nielsen, J. (2017) · ChemMedChem · doi:10.1002/cmdc.201700635 · Cited by 12
Self-citationSirakanyan, S. N., Kartsev, V. G., Geronikaki, A. A., Spinelli, D., Petrou, A., Hakobyan, E. K., Glamočlija, J., Ivanov, M., Sokóvić, M., & Hovakimyan, A. A. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200628145308 · Cited by 10
Application of dsRNA of FgPMA1 for disease control on Fusarium graminearum
Wu, L.-Y., Chen, F., Wang, P., Chong-jing, X. U., Wen, W., Hahn, M., Zhou, M., & Hou, Y. (2023) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2023.11.046 · Cited by 9
Fungal Plasma Membrane H+-ATPase: Structure, Mechanism, and Drug Discovery
Zhao, C., You, Z.-L., & Bai, L. (2024) · Journal of Fungi · doi:10.3390/jof10040273 · Cited by 11
“Tetrahydrocarbazoles [75], o-hydroxybenzylated flavanones and chalcones [70], and pyrido-thieno-pyrimidines [74] have been proposed to potentially inhibit specifically Pma1.”
BackgroundInfluentialSmall Molecule Channels Harness Membrane Potential to Concentrate Potassium in trk1Δtrk2Δ Yeast
Hou, J., Daniels, P. N., & Burke, M. D. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00180 · Cited by 9
Valproate activates the Snf1 kinase in Saccharomyces cerevisiae by decreasing the cytosolic pH
Salsaa, M., Aziz, K., Lazcano, P., Schmidtke, M. W., Tarsio, M., Hüttemann, M., Reynolds, C. A., Kane, P. M., & Greenberg, M. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101110 · Cited by 9
“ATP produced through glycolysis serves as a critical energy source, with as much as 50% being used to fuel Pma1, the proton pump in the plasma membrane that maintains the cytosolic pH (pHc) (39, 40).”
BackgroundAndrés, M. T., Fierro, P., Antuña, V., & Fierro, J. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137335 · Cited by 8
“This finding is in agreement with previous data on the fungicidal activity of HNP-1 on C. albicans cells [47].”
BackgroundMethodResultInfluentialSirakanyan, S. N., Dilip, H., Geronikaki, A. A., Spinelli, D., Kirubakaran, S., Petrou, A., Hakobyan, E. K., Kartsev, V. G., Paronikyan, E. G., Yegoryan, H. A., et al. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202302071 · Cited by 8
The Toxic Effects of Ppz1 Overexpression Involve Nha1-Mediated Deregulation of K+ and H+ Homeostasis
Albacar, M., Sácká, L., Calafí, C., Velázquez, D., Casamayor, A., Ariño, J., & Zimmermannová, O. (2021) · Journal of Fungi · doi:10.3390/jof7121010 · Cited by 10
“The activity of the Pma1 H+-ATPase is the major consumer of ATP in the cell, amounting to between 20 and 50% of the cellular ATP [51], and there is plenty of evidence that the pharmacological inhibition of Pma1 [52,53] or point mutations in the protein that lead to partial defects in the pumping activity [54] result i…”
BackgroundFisetin-Mediated Perturbations of Membrane Permeability and Intracellular pH in Candida albicans
Kim, Y. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2311.11027 · Cited by 9
“This gradient is utilized by other transporters to energize the uptake of ions and nutrients [34].”
BackgroundAndrés, M. T., Yount, N. Y., Acosta-Zaldívar, M., Yeaman, M. R., & Fierro, J. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179672 · Cited by 5
“…of each peptide able to kill 50% of cells (IC 50 ) was selected for further assays, and the previous reported microbicidal concentrations of hLf against C. albicans (5 µ M) and P. aeruginosa (1 µ M) or the peptides Lfpep (50 µ M) and BM2 (0.25 µ M) were used in control assays [9,10,21,22,32] Int.”
BackgroundMethodInfluentialPassero, P., Muthular, M., Barceló, S., Miozza, V. A., & Pérez, C. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101247 · Cited by 6
Nanoformulation of A Novel Potent Ebselen Analog for Treatment of Vulvovaginal Candidiasis
Liang, X., Menon, S., Vartak, R., Gaida, R., Wojaczyńska, E., Patel, K. R., & Billack, B. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0323 · Cited by 4
Yang, Y., Liu, X., Wang, X., Lv, W., Liu, X., Ma, L., Fu, H., Song, S., & Lei, X. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.973471 · Cited by 4
Exploring the role and mechanisms of the PMA gene in Aspergillus fumigatus
Tan, C., Jiang, S., Zhai, H., Hu, Q., Liu, C., Sun, Y., & Gao, L. (2024) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2024.2354273 · Cited by 2
“It is estimated that around 2 million people worldwide contract IFIs each year, with mortality rates soaring as high as 95% (Clausen et al. 2017; Kjellerup et al. 2017).”
InfluentialDrug Discovery and Development on Pma1, Where Are We Now? A Critical Review from 1995 to 2022
Tùng, T. T., & Nielsen, J. (2022) · ChemMedChem · doi:10.1002/cmdc.202200356 · Cited by 2
Anti-oomycete Activity of Chloramine-T against Saprolegnia Species Isolated from Rainbow Trout
Pant, V., Chanu, K. V., Thakuria, D., Bhat, R. A. H., Pandey, N., Pande, A., & Pandey, P. K. (2024) · Turkish Journal of Fisheries and Aquatic Sciences · doi:10.4194/trjfas25510 · Cited by 2
“Plasma membrane ATPase is also a vital protein for maintaining electrochemical gradient across the membrane and also serves as a preferred target for antifungal drugs (Kjellerup et al., 2017).”
When Phosphatases Go Mad: The Molecular Basis for Toxicity of Yeast Ppz1
Casamayor, A., & Ariño, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084304 · Cited by 2
A Universal Method for the Synthesis of new Heterocyclic Systems: Pyrimido[2,1‐ f ][1,2,4]triazines
Sirakanyan, S. N., Spinelli, D., Geronikaki, A. A., Kartsev, V. G., Hakobyan, E. K., Jughetsyan, H. V., Yegoryan, H. A., & Hovakimyan, A. A. (2025) · ChemistryOpen · doi:10.1002/open.202400379 · Cited by 1
Acharya, K. R., Chilakala, A. R., & Senthil‐Kumar, M. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4746-2_13 · Cited by 1
Antuña, V., Fierro, P., Fierro, J. F., Álvarez, Á. L., & Andrés, M. T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167415
“Comparable ATP accumulation and mitochondrial participation have been reported in C. albicans exposed to hLf, defensins, the BM2 peptide, and pharmacological inhibitors of Pma1 [27,28,30,31,37].”
InfluentialSynthesis and Azido-Tetrazole Tautomerism of New Methylsulfanyl Thieno[3,2-d]pyrimidine Derivatives
Sirakanyan, S. N., Hakobyan, E. K., & Hovakimyan, A. A. (2019) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428019120054
Khan, A., Koher, G., Khan, T., Grant, K., Hudson, S., Zheng, G., Lee, H. Y., Vidar, W. S., Shnaider, F. M., Chen, J., et al. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.129187 · Cited by 1
Metadata
- Authors
- Kjellerup, L., Gordon, S., Cohrt, K. O., Brown, W. D., Fuglsang, A. T., & Winther, A.-M. L.
- Affiliations
- University of Copenhagen (DK)
- Pcovery, Copenhagen, Denmark
- Corresponding author
- Kjellerup, Lasse
- Winther, Anne-Marie L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2017-07
- Volume
- 61
- Issue
- 7
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC5487681
- OpenAlex
- W2610144401
- Cited by
- 50
- References
- 35
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 2
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Funders
- Innovation Fund Denmark (4019-00019B)
- Wellcome (100480/Z/12)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Keywords
- Pma1, plasma membrane H+-ATPase, antifungal drug targets, Saccharomyces cerevisiae, membrane depolarization, plasma membrane potential, extracellular acidification, intracellular ATP, fungal membrane disruption, small molecule screening, antifungal drug development
- MeSH terms
- Antifungal Agents, Cell Membrane, Proton-Translocating ATPases, Humans, Membrane Potentials, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.